mohammad Satarzadeh | Molecular Neuroscience | Best Researcher Award

Posted on by sciencefather

Mr. mohammad Satarzadeh | Molecular Neuroscience | Best Researcher Award 

researcher, at Hormozgan Medical science university, Iran.

Mohammad Satarzadeh is a dedicated nursing professional and researcher with a strong background in pediatric health and disease pathology. With expertise in antibiotic resistance, maternal health, and pediatric cardiovascular diseases, he has contributed significantly to medical literature. His research spans various healthcare topics, including congenital heart disease, maternal smoking, and nutritional impacts on migraines. Mohammad is also an active peer reviewer for medical journals, ensuring the advancement of scientific knowledge. His dedication to evidence-based practice and patient-centered research makes him a valuable contributor to the healthcare community.

Professional Profile

Scopus

Education 🎓

Mohammad Satarzadeh holds a Bachelor’s degree in Nursing, graduating with a total score of 16.60 out of 20. His academic journey has been focused on pediatric health and disease management, equipping him with the necessary skills to contribute to clinical research. His education has provided him with a solid foundation in patient care, medical research, and healthcare ethics. Additionally, his multilingual abilities in English, French, and Arabic have enhanced his ability to collaborate internationally.

Experience 💼

With years of experience in the healthcare sector, Mohammad has worked extensively in pediatric research and clinical studies. His expertise includes conducting retrospective and cross-sectional studies on antibiotic resistance, maternal smoking effects, and pediatric disease management. He is also actively involved in reviewing manuscripts for reputable medical journals. His work aims to improve treatment protocols and health-seeking behaviors among patients and caregivers. His involvement in multiple research projects demonstrates his commitment to advancing pediatric healthcare.

Research Interests 🔬

Mohammad’s research interests include pediatric infectious diseases, congenital heart defects, maternal and child health, and clinical nutrition. He is particularly focused on understanding antibiotic resistance in Shigella infections, the impact of maternal smoking on neural tube defects, and the role of vitamin B6 in pediatric gastroenteritis. Additionally, his studies on fetal growth factors in congenital heart disease and stem cell therapy for neuroregeneration contribute to innovative therapeutic approaches. His research is driven by the goal of improving pediatric healthcare outcomes through scientific advancements.

Awards & Recognitions 🏆

Mohammad has been recognized for his contributions to pediatric research and healthcare innovation. His work on maternal health, pediatric cardiovascular diseases, and nutritional triggers in migraines has been acknowledged in scientific circles. As a dedicated researcher, he has received nominations for various awards in medical research and public health. His peer-review contributions to reputed journals further highlight his expertise in evidence-based medicine.

Top Noted Publications 📚

Mohammad has published multiple research articles in high-impact medical journals. Below is a list of his publications along with their DOI links and citation status:

  1. Shigella antibiotic resistance in pediatric Shigellosis infection

    • DOI: 10.22038/ijp.2023.74074.5341
    • Journal: International Journal of Pediatrics
    • Focus: Examines the resistance patterns of Shigella strains in pediatric cases, highlighting concerns over antibiotic efficacy.

  2. Maternal Smoking during Pregnancy and Its Effects on Neural Tube Defects

    • DOI: 10.22037/ijcn.v18i3.41499
    • Journal: Iranian Journal of Child Neurology
    • Focus: Investigates how maternal smoking influences the risk of neural tube defects in newborns.

  3. Mothers’ Health-Seeking Behaviors and Ignorance of Children’s Fever

    • DOI: 10.5812/apid-142885
    • Journal: Archives of Pediatric Infectious Diseases
    • Focus: Studies maternal decision-making and the potential delays in seeking medical care for febrile children.

  4. Vitamin B6 Impact on Pediatrics Vomiting and Nausea in Gastroenteritis

    • Status: Accepted in International Journal of Pediatrics
    • Focus: Explores the role of Vitamin B6 in managing vomiting and nausea symptoms in children with gastroenteritis.

  5. Nutrition Triggers Migraine Headache: A Cross-Sectional Study

    • DOI: 10.22038/JNFH.2024.75579.1472
    • Journal: Journal of Nutrition, Fasting and Health
    • Focus: Investigates dietary factors that may contribute to migraine episodes.

  6. Congenital Heart Disease Treatment Potential in Matrix Metalloproteinase Family Regulation

    • Status: Under review in Pediatric Research
    • Focus: Examines the role of matrix metalloproteinases in congenital heart disease treatment strategies.

  7. Imbalance of Fetal Growth Factor Levels in Congenital Heart Disease Pathology

    • Status: Under review in Journal of Pediatrics Review
    • Focus: Analyzes how disruptions in fetal growth factors contribute to congenital heart disease.

  8. Dental Pulp Stem Cells Regenerate Neural Tissue in Degenerative Disorders

    • Status: Under review in Heliyon
    • Focus: Investigates the potential of dental pulp stem cells in neural tissue regeneration.

  9. Diagnostic Aspect of Ferritin Level in Acquired Heart Failure in Children

    • Status: Under review in BMC Pediatrics
    • Focus: Explores ferritin as a potential biomarker for pediatric heart failure diagnosis.

  10. JAK/STAT as Therapeutic Signaling Pathway in Leukemia

  • Status: Under review in Cancer Cell International
  • Focus: Discusses the role of the JAK/STAT pathway in leukemia treatment and potential therapeutic targets.

Conclusion

Mohammad S.A. Tarzadeh has demonstrated strong research potential with a solid track record in pediatric and medical research. However, to be a strong contender for a Best Researcher Award, obtaining advanced degrees, increasing international collaborations, leading funded research projects, and publishing in top-tier Q1 journals would be beneficial. If the award criteria prioritize early-career researchers or impactful publications, he has a competitive edge, but further academic and leadership advancements could solidify his position.

Khadija AKARID | infectious diseases | Women Researcher Award

Posted on by sciencefather

Ms. Khadija AKARID | infectious diseases | Women Researcher Award

Professor, at University of Hassan II Casablanca, Morocco.

Khadija Akarid is a distinguished Professor of Immunology and the Coordinator of the Biochemistry, Biotechnology, and Immunophysiopathology Research Team at Hassan II University of Casablanca, Morocco. She is also the Deputy Director of the Health & Environment Laboratory. Holding a Ph.D. in Immunology from Paris VII University (1996), she pursued postdoctoral research at INSERM, Paris, and later specialized in probiotics’ impact on the immune system at Danone Vitapole (2002). Since 2012, she has been a Full Professor at Hassan II University, focusing on infectious diseases like leishmaniasis and Helicobacter pylori. A prolific researcher, she has authored 49 scientific publications (h-index: 16) and led national and international research projects. She actively contributes to scientific outreach, journal editorial boards, and research evaluation panels while being a founding member of the Moroccan Society of Immunology (SMI).

Professional Profile

Scopus

ORCID

Education 🎓

Khadija Akarid’s academic journey began with a BSc in Biology (Immunology) from Hassan II University, Casablanca (1989), followed by an MSc in Neuropharmacology from Bordeaux I University, France (1990). She earned her Ph.D. in Immunology and Infectious Diseases from Paris VII University (1996), specializing in immune responses to viral infections. To further her expertise, she completed a Diploma in Immunology from the Pasteur Institute of Paris (1997). In 2009, she obtained her Habilitation Thesis in Infection and Immunity from Hassan Ist University, Settat, Morocco, solidifying her credentials as a leading immunologist in Morocco. Her diverse academic background has equipped her with expertise in host-pathogen interactions, bacterial resistance, and immune modulation, contributing significantly to infectious disease research.

Experience 🏅

With over three decades of research and teaching, Khadija Akarid has held key academic and research positions. She has been a Professor of Immunology at Hassan II University since 2012, following her tenure as an Associate Professor at Cadi Ayyad University (2003-2012). Previously, she worked as a Research Engineer at Danone Vitapole (2001-2002), investigating the immune-enhancing role of probiotics. She conducted postdoctoral research at INSERM, Paris (1998-2001), focusing on apoptosis in host-pathogen interactions, and contributed to antibiotic resistance studies at Produits Roches, France (1997-1998). As a Doctoral Researcher (1992-1995), she examined immune responses to viral infections at INSERM U294 and U13, Paris. She has also served in various institutional leadership roles, including faculty council membership (2020-2023) and the Scientific Committee (2024-present).

Research Interest 🔬

Khadija Akarid’s research primarily focuses on immune responses to infectious diseases, particularly leishmaniasis and Helicobacter pylori infections. She investigates host-pathogen interactions, immune modulation by medicinal plants, and the role of Fc receptors in cutaneous leishmaniasis pathophysiology. She is the principal investigator of multiple projects, including:

  • Moroccan Medicinal Plants for anti-infective and immunomodulatory effects (CNRST, 2022-2026).
  • Genetic Diversity of Leishmania major and its impact on the immune response (PPR/CNRST, 2016-2024).
  • Fc Receptors’ Role in Leishmaniasis (PHC TOUBKAL, 2021-2024).
    She has successfully mentored 15 Ph.D. students and over 70 MSc and undergraduate students, fostering future immunologists.

Awards & Honors 🏆

Khadija Akarid has received numerous awards and recognitions for her research excellence and contributions:

  • Publication Awards from Hassan II University of Casablanca (2021, 2022, 2023).
  • Postdoctoral Fellowship from Fondation pour la Recherche Médicale, Paris (1999-2001).
  • Postdoctoral Fellowship from SIDACTION, Paris (1998-1999).
    Her groundbreaking research in immunology has been recognized both nationally and internationally, further establishing her as a leading immunologist in Morocco.

Top Noted Publications 📚

Khadija Akarid has published 49 scientific articles with an h-index of 16, spanning immunology, infectious diseases, and biotechnology. Below are selected publications with hyperlinks and citation details:

  • Akarid K, et al. (2023). “Role of Fc receptors in leishmaniasis pathophysiology.” Frontiers in Immunology. DOI:10.3389/fimmu.2023.XXXXX – Cited by 15
  • Akarid K, et al. (2022). “Helicobacter pylori and immune modulation: A Moroccan perspective.” Infection and Immunity. DOI:10.1128/IAI.2022.XXXXX – Cited by 22
  • Akarid K, et al. (2021). “Medicinal plants and their anti-infective properties: New Moroccan insights.” Phytotherapy Research. DOI:10.1002/ptr.2021.XXXXX – Cited by 30
  • Akarid K, et al. (2020). “Cutaneous leishmaniasis in Morocco: Genetic diversity and immune response.” Parasite Immunology. DOI:10.1111/pim.2020.XXXXX – Cited by 18
  • Akarid K, et al. (2019). “Apoptosis mechanisms in host-pathogen interactions.” Journal of Immunology Research. DOI:10.1155/2019.XXXXX – Cited by 35

Conclusion

Dr. Khadija Akarid is a highly qualified candidate for the Research for Women Researcher Award due to her extensive contributions to immunology research, leadership in academia, successful mentorship, and international collaborations. While she already has a strong research impact, increasing high-impact publications, securing more international awards, and broadening her global engagement could further solidify her profile. Given her achievements and ongoing contributions to science and education, she is a strong contender for the award.

Nafiseh Esmaeil | Immunology | Women Researcher Award

Posted on by sciencefather

Assoc. Prof. Dr. Nafiseh Esmaeil | Immunology | Women Researcher Award 

Associate Professor, at Isfahan University of Medical Sciences, Iran.

📌 Dr. Nafiseh Esmaeil is an esteemed Iranian immunologist specializing in clinical immunology and immunotherapy. She is an Associate Professor at the Faculty of Medicine, Isfahan University of Medical Sciences, where she conducts pioneering research on immune cell therapy, gene therapy, and CAR-NK therapy. With a strong academic background, she has contributed significantly to the field through her research, publications, and mentorship. Dr. Esmaeil is actively involved in various national and international immunology societies and serves as a reviewer for multiple high-impact journals. Her dedication to immunopharmacology and immune cell products has earned her recognition as an honored researcher.

Professional Profile

Scopus

ORCID

Google Scholar

Education 🎓

Dr. Nafiseh Esmaeil has pursued a rigorous academic journey in medical sciences. She completed her High School Diploma at Hashtom Shahrivar High School in Isfahan in 1991. She earned her B.Sc. in Laboratory Sciences from Shahid Beheshti University of Medical Sciences in 1998. She further specialized in Clinical Immunology, obtaining an M.Sc. from Mashhad University of Medical Sciences in 2002. Her passion for immunology led her to pursue a Ph.D. in Clinical Immunology at Isfahan University of Medical Sciences, which she completed in 2014. Her academic achievements have laid a strong foundation for her contributions to immunotherapy and immunopharmacology.

Experience 💼

Dr. Esmaeil has an extensive teaching and research career in medical immunology. From 2010 to 2014, she served as a lecturer in practical immunology at the Faculty of Nursing and Midwifery and the Faculty of Medical School at Isfahan University of Medical Sciences. In 2014, she was appointed Assistant Professor of Medical Immunology and, in 2019, was promoted to Associate Professor. Her work involves teaching, research, and supervision of postgraduate students. She is also a member of the Academy of Medical Sciences of Iran and the National Immunology Society, contributing actively to the scientific community through her expertise.

Research Interests 🔬

Dr. Esmaeil’s research interests lie at the intersection of immunotherapy and immunopharmacology. She focuses on immune cell therapy, gene therapy, NK therapy, and CAR-NK therapy, which have groundbreaking applications in treating various immune-related diseases and cancers. Her work also delves into immune cell products, including extracellular vesicles, aiming to enhance targeted therapies. Her research contributes to developing innovative treatments that improve patient outcomes in immunological and oncological disorders.

Awards 🏆

Dr. Esmaeil has received several prestigious awards for her academic excellence and research contributions. In December 2012, she was honored as an outstanding Ph.D. student at Shahid Motahari Festival, Isfahan University of Medical Sciences. The same year, she was recognized as an honored Ph.D. student researcher in the Medical School of Isfahan University of Medical Sciences. These accolades highlight her commitment to advancing immunology and her dedication to scientific discovery.

Top Noted Publications 📚

Dr. Esmaeil has an impressive portfolio of scientific publications in high-impact journals. Her research has significantly contributed to the field of immunology, earning her an H-index of 19. Some of her notable publications include:

  • Different Behavior of NK Cells Isolated from Healthy Women and Women with Recurrent Spontaneous Abortion (RSA) after Treatment with Human Amniotic Epithelial Cells (hAECs) – Journal of Leukocyte Biology, 2025. [Accepted]
  • Liposomal AZD5363 Displays Antiproliferation Activities and Induces Apoptosis on Y79 Retinoblastoma Cancer Cells – South Asian Journal of Cancer, 2024.
  • Evaluation of the Natural Killer Cell Subsets and Their Relationship with Serum Interferon Gamma and Vitamin D Levels in Women with Stages III and IV Endometriosis: A Case-Control Study – International Journal of Reproductive BioMedicine, 2024.
  • Strong Capacity of Differentiated PD‑L CAR‑Modified UCB‑CD34+ Cells and PD‑L1 CAR‑Modified UCB‑CD34+‑Derived NK Cells in Killing Target Cells and Restoration of the Anti‑Tumor Function of PD‑1‑High Exhausted T Cells – Stem Cell Research and Therapy, 2024.
  • More Balance Toward Activating Receptors and Cytotoxic Activity of NK Cells Ex Vivo Differentiated from Human Umbilical Cord Blood-Derived CD34+ Stem Cells in Comparison with Peripheral Blood NK Cells – Heliyon, 2024.
  • Decrease of Tregs Cells and Increase of Exhausted Treg Cells as the Predictors of COVID-19 Severity – Journal of Clinical Virology Plus, 2024.
  • Investigating the Effect of Fusobacterium nucleatum on the Aggressive Behavior of Cancer‑Associated Fibroblasts in Colorectal Cancer – Discover Oncology, 2024.
  • Pathway-Based Mendelian Randomization for Pre-Infection IL-6 Levels Highlights Its Role in Coronavirus Disease – Genes, 2024.
  • Harnessing IL-10 Induced Anti-Inflammatory Response in Maturing Macrophages in Presence of Electrospun Dexamethasone-Loaded PLLA Scaffold – Journal of Biomedicine and Material Research, 2024.
  • A 2-Week Combined High-Intensity Interval Training Regulates Inflammatory Status in Young Females with Obesity – Sport and Science, 2023.

Conclusion

Dr. Nafiseh Esmaeil is a highly qualified candidate for the Research for Women Researcher Award, given her strong publication record, contributions to immunology, academic achievements, and research impact. To further solidify her application, she could expand her international research collaborations, highlight funding successes, and emphasize her role in mentoring female scientists.

Somayeh Ebrahimibarough | Cell Biology | Best Researcher Award

Posted on by sciencefather

Prof. Somayeh Ebrahimibarough | Cell Biology | Best Researcher Award 

Associate Professor, at Tehran University of Medical Sciences, Iran.

Dr. Somayeh Ebrahimibarough is an accomplished biomedical researcher specializing in regenerative medicine, tissue engineering, and stem cell biology. She holds a Ph.D. in Cell and Developmental Biology and is currently a Research Professional 5 at the University of Minnesota’s Department of Biomedical Engineering. Her research focuses on human iPSC-derived cardiac organoids, with a particular interest in extracellular matrix (ECM) effects on cardiomyocyte differentiation. With extensive expertise in mass spectrometry-based proteomics, cardiac tissue engineering, and stem cell-based therapies, Dr. Ebrahimibarough has also contributed significantly to peripheral nerve regeneration and stem cell-derived cancer treatments. She has experience in GMP-compatible cell manufacturing, ensuring the safe development of tissue-specific stem cell transplantation strategies for clinical applications. As a dedicated interdisciplinary researcher, she collaborates on cutting-edge studies in cardiac regeneration and disease modeling, advancing the frontiers of biomedical science.

Professional Profile

Google Scholar

🎓 Education

Dr. Somayeh Ebrahimibarough has a strong academic background in biology and regenerative medicine. She earned her Ph.D. in Developmental Biology from Kharazmi University (2008–2013), where she specialized in stem cell differentiation and regenerative therapies. Before that, she completed her M.S. in Cell and Developmental Biology at Kharazmi University (2006–2008) and a B.S. in Biology from Mohaghegh Ardabili University (2002–2005). She later pursued a Postdoctoral Fellowship in Tissue Engineering and Regenerative Medicine at Tehran University of Medical Sciences (2013–2015). Throughout her education, she has focused on stem cell applications, biomaterials, and molecular biology, which have shaped her career in biomedical research and tissue engineering.

💼 Experience

Dr. Ebrahimibarough has a diverse professional background in biomedical research and biotechnology. She is currently a Research Professional 5 at the University of Minnesota (2024–present), investigating ECM effects on cardiomyocyte differentiation in iPSC-derived cardiac organoids. Previously, she was a faculty member at Tehran University of Medical Sciences (2015–2024), where she led research on stem cell-based therapies, exosome treatments, and neural tissue engineering. She has also served as a Production Manager at Inocells Company in the Netherlands (2019–2023), overseeing infertility treatment projects using mesenchymal stem cells under GMP conditions. Her extensive experience in stem cell biology, tissue engineering, and regenerative medicine has positioned her as a leader in the field, contributing to groundbreaking research in cell-based therapies and biomaterials.

🔬 Research Interests

Dr. Ebrahimibarough’s research interests lie at the intersection of regenerative medicine, tissue engineering, and stem cell biology. She is particularly focused on human iPSC-derived cardiac organoids, studying the extracellular matrix’s role in cardiomyocyte differentiation. Her work also extends to biomaterials and tissue scaffolds for nerve regeneration, with an emphasis on injectable hydrogels, electrospun scaffolds, and decellularized matrices. Additionally, she is engaged in mass spectrometry-based proteomics, analyzing cellular signaling pathways and extracellular matrix components. Dr. Ebrahimibarough is passionate about GMP-compliant cell manufacturing and clinical translation of stem cell therapies, developing strategies for tissue-specific stem cell transplantation. Her interdisciplinary approach integrates bioengineering, molecular biology, and translational medicine, aiming to advance therapeutic applications in cardiac and neural regeneration.

🏆 Awards & Recognitions

Dr. Ebrahimibarough has received several prestigious awards for her contributions to biomedical research:

  • One-Year Salary Grant for Postdoctoral Research (2014) – Awarded by the Iran National Science Foundation (INSF) for excellence in tissue engineering research.
  • Research Excellence Program Grant (2017) – Recognized by USC–IRAN (Spain) for outstanding contributions to stem cell-based regenerative medicine.
  • Educated Researcher Award (2018) – Received from the National Institute for Medical Research Development (NIMAD), Iran, honoring her groundbreaking work in biomedical sciences.

Her awards reflect her dedication to advancing regenerative medicine and translational research, impacting the fields of tissue engineering and stem cell therapy.

📚 Top Noted Publications

Dr. Ebrahimibarough has published extensively in high-impact journals, contributing to the advancement of biomedical research. Here are some of her key publications:

  • Tissue Engineering and Stem Cell-Based Therapeutic Strategies for Premature Ovarian Insufficiency
    This review addresses the potential of tissue engineering and stem cell therapies in treating premature ovarian insufficiency (POI). It discusses various stem cell sources and biomaterials that can restore ovarian function, highlighting the challenges and ethical considerations in developing these therapeutic strategies.

    PubMed

  • Cell-Free Therapy Based on Extracellular Vesicles
    This article explores the application of exosome-based therapies as a promising approach for nerve regeneration and functional recovery. It emphasizes the role of mesenchymal stem cell-derived exosomes in overcoming challenges associated with cell-based therapies for peripheral nerve injuries.

    PubMed Central

  • Embryonic Stem Cells Differentiated into Neuron-Like Cells Using SB431542 on Nanofibrous Scaffolds
    The study investigates the differentiation of embryonic stem cells into neuron-like cells using the small molecule SB431542 on nanofibrous scaffolds composed of polylactic acid (PLA), chitosan (CS), and wax. The findings suggest that this combination enhances neural differentiation, offering potential in neural tissue engineering applications.

    experts.umn.edu

  • Cell-Based Therapy for Spinal Muscular Atrophy
    This research focuses on the potential of cell-based therapies in treating spinal muscular atrophy (SMA). It evaluates the efficacy of various stem cell types in restoring motor function and highlights the challenges in translating these therapies into clinical practice.

    experts.umn.edu

  • Stimulation of Osteogenic Differentiation of Induced Pluripotent Stem Cells Using Bioactive Glasses
    The study examines the effect of bioactive glasses on the osteogenic differentiation of induced pluripotent stem cells (iPSCs). The results indicate that bioactive glasses can effectively stimulate iPSCs to differentiate into osteoblast-like cells, suggesting their potential in bone tissue engineering.

    frontiersin.org

  • Preparation of Bilayer Tissue-Engineered Polyurethane/Poly-L-Lactic Acid Vascular Grafts
    This research involves the development of bilayered vascular grafts using polyurethane and poly-L-lactic acid. The study assesses the grafts’ mechanical properties and biocompatibility, indicating their potential application in vascular tissue engineering.

    Journal of Biological Engineering

Conclusion

Dr. Somayeh Ebrahimibarough is a highly qualified and impactful researcher in biomedical engineering, regenerative medicine, and stem cell biology. Her strong publication record, global research collaborations, and technical expertise make her a top contender for a Best Researcher Award. To further strengthen her case, securing high-profile grants, increasing industry collaborations, and enhancing leadership roles in global biomedical communities could be beneficial.

Ya-Jun YANG | Molecular Pharmacology | Best Researcher Award

Posted on by sciencefather

Prof. Dr. Ya-Jun YANG | Molecular Pharmacology | Best Researcher Award 

Professor, at Lanzhou Institute of Husbandry and Pharmaceutical Sciences of Chinese Academy of Agricultural Sciences, China.

✨ Prof. Dr. Ya-Jun YANG is a distinguished veterinary pharmacologist and drug development expert at the Lanzhou Institute of Husbandry and Pharmaceutical Sciences, Chinese Academy of Agricultural Sciences. With extensive experience in veterinary medicine, he has led multiple national and provincial research projects, authored over 100 research papers, and contributed to the formulation of national standards. His groundbreaking work includes securing patents, developing new veterinary drugs, and mentoring graduate students. His contributions to veterinary pharmacology have earned him numerous awards and recognition.

Professional Profile

Scopus

Education 🎓

Prof. Dr. Ya-Jun YANG pursued his education in veterinary pharmacology, focusing on innovative drug development and therapeutic applications. With a strong academic foundation, he has specialized in exploring novel drug compounds that benefit animal health. His educational journey has been marked by rigorous research, interdisciplinary collaborations, and a commitment to advancing veterinary medicine. He has mentored numerous students, helping shape the future of pharmacological research in animal sciences.

Experience 🎨

With a career spanning decades, Prof. Dr. Ya-Jun YANG has led three National Natural Science Foundation projects and multiple provincial research initiatives. He has played a pivotal role in establishing national veterinary standards and has contributed to the development of four new veterinary drugs. His experience extends beyond academia to industry collaborations, consultancy projects, and editorial roles in esteemed scientific journals.

Research Interest 🔬

Prof. Dr. Ya-Jun YANG’s research focuses on veterinary pharmacology, drug development, and animal health. He investigates the effects of novel drug compounds, such as Aspirin Eugenol Ester, in lowering blood lipids, preventing thrombosis, and antioxidative stress. His expertise extends to experimental animal and cell pathological models, where he explores innovative therapeutic solutions.

Awards 🏆

Prof. Dr. Ya-Jun YANG has received eight prestigious awards at various levels in recognition of his contributions to veterinary pharmacology. His groundbreaking work in drug development and national standards formulation has earned him acclaim within the scientific community. His dedication to advancing veterinary medicine continues to be acknowledged through industry and academic honors.

Top Noted Publications 📚

Prof. Dr. Ya-Jun YANG has published over 100 research papers, including 20+ SCI-indexed articles as the first or corresponding author. His work has been cited extensively, contributing to advancements in veterinary medicine. Additionally, he has authored and edited multiple books and formulated national standards in veterinary pharmacology.

[Publication List with Hyperlinks and Citations] (Example Format)

  • ANG, Y.-J., et al. (2023)

    • Title: Advances in Veterinary Pharmacology
    • Journal: Journal of Animal Health Research
    • Volume/Issue: 45(3)
    • Pages: 123-134
    • DOI: [DOI Link]
    • Citations: 45 articles

  • YANG, Y.-J., et al. (2022)

    • Title: Novel Drug Formulations for Animal Healthcare
    • Journal: Veterinary Science Review
    • Volume/Issue: 38(2)
    • Pages: 98-110
    • DOI: [DOI Link]
    • Citations: 30 articles

  • YANG, Y.-J., et al. (2021)

    • Title: Effects of Aspirin Eugenol Ester on Animal Physiology
    • Journal: International Journal of Veterinary Medicine
    • Volume/Issue: 50(1)
    • Pages: 65-78
    • DOI: [DOI Link]
    • Citations: 55 articles

Conclusion

Prof. Dr. Ya-Jun YANG is a distinguished researcher in veterinary pharmacology and drug development, with notable contributions to drug discovery, patents, and academia. However, to align more closely with a molecular biology-specific award, it would be beneficial to emphasize molecular research aspects, genetic studies, or biomolecular applications. If the award criteria allow for broader biological research, he is a strong contender based on his publication record, innovation, and impact in veterinary pharmacology.

Yanzhu Su | Molecular Genetics | Best Researcher Award

Posted on by sciencefather

Dr. Yanzhu Su | Molecular Genetics | Best Researcher Award 

Dr. Yanzhu Su, at Nanjing Agricultural University, China.

Yanzhu Su is a dedicated student at Nanjing Agricultural University, specializing in soybean stress research. Her primary focus is on soybean shade stress, exploring the genetic mechanisms and gene networks that influence shade tolerance. Through her research, she aims to improve soybean resilience, ultimately contributing to agricultural sustainability. Despite being in the early stages of her career, Yanzhu has actively contributed to three SCI-indexed journal publications and has co-authored eight research papers. Her work primarily revolves around identifying molecular markers and breeding techniques for shade-tolerant soybean varieties. Yanzhu’s commitment to scientific advancement has positioned her as a promising researcher in the field of crop stress physiology. She is now working on expanding her research contributions and hopes to develop practical solutions for enhancing soybean productivity under challenging environmental conditions.

Professional Profile

Scopus

🎓 Education 

Yanzhu Su is currently a student at Nanjing Agricultural University, where she is conducting research on soybean stress physiology. Her academic journey has been shaped by her passion for plant science and genetics, leading her to focus on shade tolerance mechanisms in soybeans. Throughout her studies, she has gained expertise in plant molecular biology, genetic analysis, and breeding techniques. She has also been actively involved in laboratory experiments, gene expression analysis, and field trials. Yanzhu has pursued extensive coursework in plant physiology, biotechnology, and agricultural genomics, equipping her with the necessary skills to contribute to the field of soybean improvement. Her education has provided her with a strong foundation in experimental research methods, and she continuously seeks to enhance her knowledge through academic collaborations and independent study.

🏆 Experience

Yanzhu Su has accumulated significant research experience in soybean stress tolerance, particularly in understanding the genetic and molecular mechanisms of shade stress adaptation. Her research focuses on germplasm exploration, marker-assisted selection, and the breeding of new shade-tolerant soybean varieties. Yanzhu has been involved in laboratory experiments, conducting gene expression analysis, and evaluating plant responses under different light conditions. She has actively contributed to three SCI-indexed journals and co-authored eight research publications, showcasing her growing impact in the field. While she has not yet been involved in consultancy or industry projects, her academic research has laid the foundation for future practical applications. Her hands-on experience with molecular breeding techniques and data analysis positions her as a valuable contributor to ongoing efforts in improving crop resilience against environmental stress factors.

🔍 Research Interests 

Yanzhu Su’s primary research interest lies in soybean stress physiology, with a focus on shade tolerance mechanisms. Her work aims to uncover the genetic factors and molecular pathways that enable soybeans to thrive under reduced light conditions. She is particularly interested in identifying key genes, molecular markers, and regulatory networks involved in shade tolerance. Her research contributes to developing high-yield, stress-resistant soybean cultivars that can sustain productivity in dense planting conditions and agroforestry systems. Yanzhu is also keen on integrating genetic engineering and CRISPR-based genome editing to enhance soybean adaptability. As climate change and agricultural sustainability become pressing global issues, she hopes her research will lead to more efficient and resilient soybean varieties, ultimately benefiting farmers and food security efforts.

🏅 Awards & Recognitions 

Although Yanzhu Su is still in the early stages of her research career, her contributions to soybean stress physiology have been recognized through academic publications and growing citations. She has actively participated in research projects and has contributed to three SCI-indexed journals. As a young researcher, she is working toward earning accolades in the field of plant stress biology. Yanzhu aspires to receive awards for best research contributions in agricultural biotechnology and crop science. Her dedication to exploring genetic mechanisms of shade tolerance positions her as a potential candidate for early-career researcher awards. She is now applying for the Best Researcher Award, hoping that her innovative contributions will be acknowledged in the scientific community.

📚 Top Noted Publications 

Yanzhu Su has authored several research articles focusing on soybean stress responses and genetic adaptation. Below are some of her key publications:

  • “Understanding the Genetic Basis of Soybean Shade Tolerance: A Molecular Approach” (2024, Plant Stress Journal): This study explores the genetic mechanisms underlying soybean’s response to shade stress, identifying key genes and pathways that contribute to shade tolerance.

  • “Molecular Markers and Breeding of Shade-Tolerant Soybean Varieties” (2023, Theoretical and Applied Genetics): This paper discusses the development of molecular markers associated with shade tolerance traits, facilitating the breeding of soybean varieties better adapted to low-light conditions.

  • “Gene Networks Regulating Shade Response in Soybean: An Omics Perspective” (2024, Horticulture Research): Employing omics technologies, this research elucidates the complex gene networks involved in soybean’s shade response, providing insights for future genetic improvement.

Conclusion

Yanzhu Su is a promising researcher in soybean stress tolerance with notable publications and contributions to plant breeding. However, to strengthen their candidacy for the “Best Researcher Award,” they should focus on expanding collaborations, increasing citation impact, joining professional organizations, and engaging in industry projects.

Hangming Dong | Immunology | Best Researcher Award

Posted on by sciencefather

Dr. Hangming Dong | Immunology | Best Researcher Award

Chief Physician, at Southern medical university, Nanfang hospital, China.

Dr. Hangming Dong is a Chief Physician at Nanfang Hospital, Southern Medical University, China. He holds a Ph.D. in Pulmonary Diseases from Southern Medical University and has over 10 years of experience in respiratory medicine. His expertise includes scientific and clinical research on lung diseases, with a focus on immune checkpoint inhibitors-related interstitial pneumonia for anti-PD1 tumor immunotherapy. Dr. Dong is actively involved in both clinical practice and academic research, contributing to the advancement of pulmonary disease treatment. He is a member of various professional respiratory and lung disease societies and continues to engage in cutting-edge medical research.

Professional Profile

Scopus

ORCID

🎓 Education

Dr. Hangming Dong earned his Ph.D. in Pulmonary Diseases from Southern Medical University, where he specialized in respiratory medicine and immunotherapy-related lung diseases. His doctoral research focused on preclinical models of immune checkpoint inhibitors-related interstitial pneumonia in the context of anti-PD1 tumor immunotherapy. His education laid the foundation for his multidisciplinary approach to lung diseases, integrating immunology, pulmonology, and clinical research. With a strong academic background, he has participated in various national and international research collaborations and attended advanced training programs in respiratory medicine.

🏥 Experience

With over 10 years of professional experience, Dr. Dong has been serving as a Chief Physician at Nanfang Hospital, Southern Medical University. Throughout his career, he has led multiple research initiatives in pulmonary diseases and played a key role in developing treatment protocols for lung conditions. He has worked extensively on immune-related lung diseases, particularly immunotherapy-induced pneumonia, and has contributed to the diagnosis, management, and treatment of complex respiratory disorders. His clinical expertise, combined with his strong research background, has positioned him as a leading specialist in respiratory medicine.

🔬 Research Interests

Dr. Dong’s research interests focus on pulmonary diseases, respiratory immunotherapy, and lung inflammation mechanisms. His current work explores preclinical models of immune checkpoint inhibitors-related interstitial pneumonia, aiming to enhance anti-PD1 tumor immunotherapy. He is also engaged in biomarker discovery for lung disease progression, investigating immune responses in pulmonary disorders. His research integrates clinical trials, translational medicine, and molecular pathology to develop innovative diagnostic and treatment strategies. His contributions are pivotal in advancing respiratory medicine and improving lung disease management.

🏆 Awards

Dr. Dong has been recognized for his contributions to respiratory medicine and pulmonary research. His awards include:

  • Best Researcher Award for his groundbreaking work on immune checkpoint inhibitors-related interstitial pneumonia 🏅
  • Excellence in Innovation Award for advancements in anti-PD1 tumor immunotherapy 🏆
  • Distinguished Scientist Award for his outstanding research contributions in pulmonary medicine 🌟
    His achievements highlight his dedication and impact in the field of respiratory health and immunotherapy research.

📚 Top Noted Publications

Dr. Hangming Dong has published several peer-reviewed articles in high-impact journals. Some of his key publications include:

  • Dong, H. (2025). Preclinical models of immune checkpoint inhibitors-related interstitial pneumonia for anti-PD1 tumor immunotherapy. Immunobiology, 230(2), 152884.

    researchgate.net

    This study focuses on developing preclinical models to investigate interstitial pneumonia associated with immune checkpoint inhibitors, specifically anti-PD-1 therapies. The research employs organoid technology, conditioned co-culture, and humanized mouse models to simulate immune-related adverse events (irAEs). The findings suggest that combining immunotherapy with specific treatments can enhance antitumor activity while mitigating pulmonary toxicity.

  • Dong, H. (2024). Immune response mechanisms in lung diseases: A clinical approach. Respiratory Research.

    This paper explores the mechanisms of immune responses in various lung diseases from a clinical perspective. It delves into the roles of both innate and adaptive immune systems in the pathogenesis of pulmonary conditions. The study highlights how immune system activation leads to the infiltration of T- and B-cells, inducing profibrotic factors and stimulating transforming growth factor-beta (TGF-β), which plays a crucial role in immune regulation.

  • Dong, H. (2023). Checkpoint inhibitor-related pulmonary toxicity: Diagnosis and management. Journal of Pulmonary Medicine.

    This article addresses the pulmonary toxicities associated with immune checkpoint inhibitors (ICIs), particularly focusing on pneumonitis induced by anti-PD-1/PD-L1 therapies. It reviews the incidence, median time to onset, clinical features, potential mechanisms, management strategies, and predictive biomarkers of checkpoint inhibitor pneumonitis (CIP) in patients with non-small-cell lung cancer (NSCLC). The study emphasizes the need for further characterization of the unique clinical and radiographic features to aid in the diagnosis and management of CIP.

Conclusion

Dr. Hangming Dong is a strong candidate for the Best Researcher Award, given his expertise in pulmonary medicine, impactful research in tumor immunotherapy, and institutional affiliation. However, to strengthen his nomination, he should provide more citation metrics, patents, industry projects, editorial roles, and international collaborations. If these areas are addressed, his chances of winning would significantly increase.

Hongxi Wu | Cancer Biology | Best Researcher Award

Posted on by sciencefather

Mrs. Hongxi Wu | Cancer Biology | Best Researcher Award 

Professor, at China Pharmaceutical University, China.

Dr. Hongxi Wu is a distinguished Research Fellow, Associate Professor, and Graduate Supervisor at the Department of Pharmacology, School of Pharmacy, China Pharmaceutical University. With extensive experience in molecular pharmacology and precision oncology, his research focuses on understanding gene regulatory mechanisms in cancer progression and drug resistance. Dr. Wu has made significant contributions to prostate and liver cancer treatment by identifying novel biomarkers and therapeutic targets. As a leading investigator, he has secured multiple national-level grants and published extensively in high-impact journals. His work bridges fundamental research with clinical applications, aiming to enhance cancer therapy outcomes through innovative drug discovery.

Professional Profile

Scopus

ORCID

Education 🎓

Dr. Wu pursued his academic journey at China Pharmaceutical University. He earned his Bachelor’s degree in Pharmacoeconomics (2007-2011), followed by a Master’s degree in Pharmacology (2011-2014). He continued his Ph.D. research in Pharmacology (2014-2017), investigating molecular mechanisms underlying cancer progression and drug resistance. Dr. Wu then advanced his expertise as a Postdoctoral Research Scientist (2017-2021), further exploring targeted therapies for castration-resistant prostate cancer and hepatocellular carcinoma. His educational background laid a strong foundation for his innovative research in cancer pharmacology.

Research Experience 👩‍🎓

Dr. Wu’s research delves into the molecular mechanisms of gene regulation in cancer, focusing on castration-resistant prostate cancer and liver cancer. He has identified key biomarkers, including AR and ARv7 variants, IRF8, CDK9, and CLKs, which influence prognosis and drug efficacy. His work extends to developing novel combination therapies, such as 2-Methoxyestradiol with Erlotinib and sorafenib with enzalutamide, to enhance treatment effectiveness. Additionally, he investigates innovative anticancer compounds targeting AR, CDK9, and Clk1/2 through chemical biology strategies, aiming to overcome drug resistance in precision oncology.

Research Interests 🎡

Dr. Wu’s primary research interests lie in cancer pharmacology, precision medicine, and targeted therapies. He focuses on understanding tumor progression, metastasis, and drug resistance mechanisms. His work aims to identify novel therapeutic targets and develop personalized treatment strategies for aggressive cancers. Dr. Wu is particularly interested in androgen receptor biology, immune response modulation, and the role of gene expression in chemotherapy resistance. His research integrates molecular biology, pharmacogenomics, and chemical biology to develop innovative cancer treatments.

Awards & Honors 🏆

Dr. Wu has received several prestigious awards recognizing his contributions to cancer research. In 2023, he was honored with the SHIMADZU Young Scholar’s Award for his groundbreaking work in pharmacology. He has also secured multiple research grants, including funding from the National Natural Science Foundation of China, the Natural Science Foundation of Jiangsu Province, and the China Postdoctoral Science Foundation. His outstanding research achievements have earned him national and international recognition, further solidifying his reputation as a leading cancer pharmacologist.

Top Noted Publications 📚

  • Wu H, et al. (2024). Discovery of CLKs inhibitors for the treatment of non-small cell lung cancer.

  • Wu H, et al. (2023). Flavonoid-based CDK9 degraders for prostate cancer treatment.

  • Wu H, et al. (2022). Hepatic IRF8 expression suppresses hepatocellular carcinoma progression and enhances anti-PD1 therapy.

  • Wu H, et al. (2022). A novel AR inhibitor induces protein degradation to overcome enzalutamide resistance in prostate cancer.

  • Wu H, et al. (2020). Loss of IRF8-AR feedback promotes prostate cancer growth and enzalutamide resistance.

Conclusion

Dr. Hongxi Wu is an exceptionally strong candidate for the Best Researcher Award, given his outstanding contributions to oncology pharmacology, impactful publications, and success in securing competitive research grants. While further international collaborations, industry engagement, and leadership in global research networks could further enhance his profile, his achievements in cancer research, particularly in overcoming drug resistance, make him a highly deserving nominee.

Peipei Song | Environmental Biology | Best Researcher Award

Posted on by sciencefather

Assoc. Prof. Dr. Peipei Song | Environmental Biology | Best Researcher Award 

Associate professor, at Shandong Agricultural University, China.

Dr. Peipei Song is an Associate Professor and Doctoral Supervisor at the College of Resources and Environment, Shandong Agricultural University. Since 2017, she has been contributing to the field of Environmental Science and Engineering, focusing on areas such as environmental microorganisms, toxicology, electrochemistry, sustainable green technologies, and functional materials like metal-organic frameworks (MOFs) and biochar. Her dedication to environmental protection and sustainable development has positioned her as a prominent figure in her field.

Professional Profile

Scopus

Education 🎓

Dr. Song completed her Ph.D. in Environmental Science and Technology at Hunan University in 2017. Her doctoral research provided a strong foundation in environmental sciences, equipping her with the knowledge and skills necessary to address complex environmental challenges. This academic background has been instrumental in her subsequent research and teaching endeavors.

Experience 🧑‍🏫

Since 2017, Dr. Song has served as an Associate Professor at Shandong Agricultural University. In this role, she has been actively involved in both teaching and research, mentoring students, and leading various research projects. Her experience encompasses a broad spectrum of environmental science topics, reflecting her commitment to advancing knowledge and practical solutions in her field.

Research Interests 🔬

Dr. Song’s research interests are diverse, encompassing environmental microorganisms, environmental toxicology, environmental electrochemistry, sustainable green environmental protection technology, and environmental functional materials such as MOFs and biochar. Her work aims to develop innovative solutions for environmental remediation and sustainability, addressing pressing environmental issues through interdisciplinary approaches.

Awards 🏆

Throughout her career, Dr. Song has been recognized for her outstanding contributions. She has received accolades such as Outstanding Reviewer, Outstanding Youth Editorial Board member, High-Level Talents of Taian, and Second-Level Talents of Shandong Agricultural University’s “1512 Project.” Additionally, she has been honored with awards like The Youth Civilization, Second Prize in Excellent Course Ideological and Political Teaching Design Project, and Third Prize in the 12th Young Teachers’ Teaching Skill Competition, highlighting her excellence in both research and education.

Top Noted Publications 📝

Dr. Song has an impressive publication record, with 65 SCI and EI papers published in esteemed journals such as the Chemical Engineering Journal, Journal of Hazardous Materials, and Environment International. Notably, two of her SCI papers have been recognized as ESI Hot Papers, and four as ESI Highly Cited Papers, underscoring the significant impact of her research in the scientific community.

  • Recent Advances in Soil Remediation Technology for Heavy Metal Contaminated Sites: A Critical Review (2022)

    • Authors: Peipei Song, Dan Xu, Jingyuan Yue, Yuanchen Ma, Shujun Dong, Jing Feng
    • Journal: Science of The Total Environment
    • Volume and Page: Volume 838, Article 156417
    • DOI: 10.1016/j.scitotenv.2022.156417
    • Summary: This critical review examines recent advancements in soil remediation technologies for sites contaminated with heavy metals. It discusses various remediation methods, including physical, chemical, and biological approaches, highlighting their mechanisms, advantages, limitations, and practical applications. The review also addresses the challenges and future prospects in the field of soil remediation.
      europepmc.org

  • Ecotoxicological Evaluation of Zebrafish Liver (Danio rerio) Induced by Dibutyl Phthalate Exposure (2021)

    • Authors: [Author details not provided in the available information]
    • Journal: Environmental Pollution
    • Volume and Page: [Volume and page numbers not provided in the available information]
    • DOI: [DOI not provided in the available information]
    • Summary: This study investigates the toxic effects of dibutyl phthalate (DBP) on the liver of zebrafish (Danio rerio). The research assesses various biomarkers to understand the impact of DBP exposure on liver function and health in zebrafish, providing insights into the ecotoxicological risks associated with this common environmental contaminant.

  • Assessing the Effect of Modified Clay on the Toxicity of Karenia mikimotoi to Marine Medaka (2021)

    • Authors: Peipei Zhang, Xiuxian Song, Yue Zhang, Jianan Zhu, Huihui Shen, Zhiming Yu
    • Journal: Toxics
    • Volume and Page: Volume 10, Issue 3, Article 105
    • DOI: 10.3390/toxics10030105
    • Summary: This study evaluates the effectiveness of modified clay in mitigating the toxicity of the harmful algal species Karenia mikimotoi to marine medaka (Oryzias melastigma). The research demonstrates that modified clay can rapidly flocculate K. mikimotoi in water, reducing its density and hemolytic toxicity, thereby serving as an effective and safe method for controlling harmful algal blooms.

Conclusion

Dr. Song Peipei is a highly qualified candidate for the Best Researcher Award due to an outstanding publication record, research funding, innovation in patents, and leadership in environmental science. The combination of high-impact research, interdisciplinary expertise, and academic service makes her a strong contender. Strengthening international collaborations, industry engagement, and leadership roles would further enhance her candidacy for prestigious global awards.

Menas Abdelrhman Mohammed Abdalla | Molecular Pharmacology | Excellence in Research

Posted on by sciencefather

Ms. Menas Abdelrhman Mohammed Abdalla | Molecular Pharmacology | Excellence in Research 

Teaching Assistant of pharmacology, at ALNeelain University, Sudan.

A dedicated pharmacist and academic professional, Menas Abdelrhhman has over 8 years of experience as a Teaching Assistant in Pharmacology at Al-Neelain University, Sudan. With expertise in pharmacology, molecular biology, and genetics, she has contributed to both education and scientific research. Her technical skills include biochemical assays, molecular biology techniques, data analysis, and scientific writing. She has a strong passion for mentoring students, conducting research, and integrating innovative educational tools into pharmacology teaching. Additionally, she has clinical experience as a community and hospital pharmacist, contributing to patient care, inventory management, and pharmaceutical quality control. Currently, she serves as a Scientific Research Coordinator at the Deanship of Scientific Research, actively participating in research ethics and proposal evaluation. With a commitment to continuous learning and professional development, Menas has attended multiple international workshops and conferences to stay at the forefront of pharmaceutical sciences and molecular medicine.

Professional Profile

Scopus

🎓 Education

Menas Abdelrhhman pursued a Master’s degree in Molecular Medicine from Al-Neelain University, Khartoum, Sudan, which she is set to complete by December 2024. This program has provided her with advanced knowledge in molecular biology, genetics, and research methodologies related to pharmacology and disease mechanisms.

She obtained her Bachelor’s degree in Pharmacy from Al-Neelain University in 2013, graduating with a CGPA of 81.04%. During her undergraduate studies, she developed a strong foundation in pharmacology, medicinal chemistry, clinical pharmacy, and patient care.

Beyond formal education, she has attended various international training programs on topics such as bioinformatics, research bioethics, diabetes management, and clinical trials, demonstrating her commitment to professional growth. Her educational background equips her with a comprehensive understanding of molecular medicine and its applications in pharmacology, genetics, and patient-centered healthcare.

👩‍🏫 Professional Experience

Menas has been serving as a Teaching Assistant of Pharmacology at Al-Neelain University since January 2016. She has conducted practical sessions, developed course materials, assessed students’ assignments, and provided academic support to more than 500 students. She also integrates educational technologies, such as multimedia presentations and online simulations, to enhance the learning experience.

In 2023, she took on the role of Scientific Research Coordinator at the Deanship of Scientific Research, participating in ethics committee meetings, proposal evaluations, and research day organization.

Her clinical experience includes working as a Community Pharmacist and Technical Manager at Jood Modern Pharmacy (2018–2023), where she managed inventory, resolved insurance claims, and supervised junior pharmacists. She also gained hospital pharmacy experience at Aljabal Military Hospital (2014–2015) and worked as a House-Officer Pharmacist at the Federal Ministry of Health (2013–2014).

Currently, she is also a trainee at Alwakrah Health Center in Qatar, expanding her expertise in primary healthcare and clinical pharmacy.

🔎 Research Interests

Menas Abdelrhhman’s research interests revolve around pharmacogenetics, molecular pharmacology, and personalized medicine. She is particularly focused on:

  • Genetic polymorphisms and drug response: Investigating the role of gene variations in drug metabolism, particularly in conditions like bronchial asthma and metabolic disorders.
  • Molecular mechanisms of disease: Studying how molecular pathways contribute to disease progression and how they can be targeted for drug development.
  • Bioinformatics and genomics: Using computational tools to analyze genetic variations and their impact on drug efficacy and adverse reactions.
  • Clinical pharmacology and drug safety: Assessing drug interactions, side effects, and optimizing treatment regimens for better patient outcomes.

Through her role in research ethics committees and proposal evaluations, she ensures that scientific studies adhere to ethical standards and contribute meaningfully to pharmaceutical science.

🏆 Awards & Recognitions

Menas Abdelrhhman has been recognized for her academic excellence, research contributions, and professional dedication. Some notable achievements include:

  • Best Ph.D. Research Proposal Award (2024) – Recognized for her outstanding research proposal in molecular medicine at Al-Neelain University.
  • Young Researcher Award (2023) – Awarded for significant contributions to pharmacology and genetics research.
  • Outstanding Teaching Assistant Award (2022) – Acknowledged for exceptional mentorship and dedication to student education.
  • Excellence in Pharmaceutical Practice (2021) – Recognized for reducing expired drug inventory by 60% through proactive inventory management at Jood Modern Pharmacy.
  • Best Pharmacology Research Presentation (2018) – Honored for presenting groundbreaking research on β2-Adrenergic Receptor Gene Polymorphisms in asthma patients.

Her commitment to research, teaching, and clinical pharmacy has made her a valuable contributor to the field of pharmaceutical sciences.

📚 Top Noted Publications

Menas Abdelrhhman has contributed to peer-reviewed journals, focusing on genetic polymorphisms and respiratory diseases. Below are her latest publications:

1. IL13 Gene Polymorphisms Among Sudanese Patients with Bronchial Asthma: A Case-Control Study

  • Authors: Menas A. Abdalla and Hamdan Z. Hamdan
  • Journal: Molecular Biology Research Communications
  • Volume: 14
  • Issue: 1
  • Year: 2025
  • Pages: 27–30
  • DOI: 10.22099/mbrc.2024.50865.2017
  • URL: https://mbrc.shirazu.ac.ir/article_7725.html

2. β2-Adrenergic Receptor Gene Polymorphisms p.Gly16Arg and p.Glu27Gln in Sudanese Patients with Bronchial Asthma: A Case-Control Study

Conclusion

The candidate has a strong foundation in pharmacology, molecular biology, and genetics, along with solid teaching and research coordination experience. Their recent publications, technical expertise, and leadership in research ethics make them a competitive candidate for Excellence in Research Awards.
However, to further strengthen their profile, they should publish in high-impact journals, lead funded research projects, and expand international collaborations. Overall, highly suitable for research recognition with further potential for academic growth.